These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 31967847)

  • 1. Early angiogenic proteins associated with high risk for bronchopulmonary dysplasia and pulmonary hypertension in preterm infants.
    Arjaans S; Wagner BD; Mourani PM; Mandell EW; Poindexter BB; Berger RMF; Abman SH
    Am J Physiol Lung Cell Mol Physiol; 2020 Apr; 318(4):L644-L654. PubMed ID: 31967847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia.
    Mourani PM; Sontag MK; Younoszai A; Miller JI; Kinsella JP; Baker CD; Poindexter BB; Ingram DA; Abman SH
    Am J Respir Crit Care Med; 2015 Jan; 191(1):87-95. PubMed ID: 25389562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diseases associated with prematurity in correlation with N-terminal pro-brain natriuretic peptide levels during the early postnatal life.
    Fritz AS; Keller T; Kribs A; Hünseler C
    Eur J Pediatr; 2023 Jul; 182(7):3075-3082. PubMed ID: 37072630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cord Blood Biomarkers of Placental Maternal Vascular Underperfusion Predict Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension.
    Mestan KK; Gotteiner N; Porta N; Grobman W; Su EJ; Ernst LM
    J Pediatr; 2017 Jun; 185():33-41. PubMed ID: 28162769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural History of Postnatal Cardiopulmonary Adaptation in Infants Born Extremely Preterm and Risk for Death or Bronchopulmonary Dysplasia.
    Mirza H; Garcia JA; Crawford E; Pepe J; Zussman M; Wadhawan R; Oh W
    J Pediatr; 2018 Jul; 198():187-193.e1. PubMed ID: 29625730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH): Potential Role of the FGF Signaling Pathway in the Development of the Pulmonary Vascular System.
    Chao CM; Chong L; Chu X; Shrestha A; Behnke J; Ehrhardt H; Zhang J; Chen C; Bellusci S
    Cells; 2020 Aug; 9(8):. PubMed ID: 32796770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early pulmonary hypertension is a risk factor for bronchopulmonary dysplasia-associated late pulmonary hypertension in extremely preterm infants.
    Kim HH; Sung SI; Yang MS; Han YS; Kim HS; Ahn SY; Jeon GW; Chang YS; Park WS
    Sci Rep; 2021 May; 11(1):11206. PubMed ID: 34045608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring clinical, echocardiographic and molecular biomarkers to predict bronchopulmonary dysplasia.
    Alvarez-Fuente M; Moreno L; Lopez-Ortego P; Arruza L; Avila-Alvarez A; Muro M; Gutierrez E; Zozaya C; Sanchez-Helguera G; Elorza D; Martinez-Ramas A; Villar G; Labrandero C; Martinez L; Casado T; Cuadrado I; Del Cerro MJ
    PLoS One; 2019; 14(3):e0213210. PubMed ID: 30840669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BNP, troponin I, and YKL-40 as screening markers in extremely preterm infants at risk for pulmonary hypertension associated with bronchopulmonary dysplasia.
    König K; Guy KJ; Nold-Petry CA; Barfield CP; Walsh G; Drew SM; Veldman A; Nold MF; Casalaz DM
    Am J Physiol Lung Cell Mol Physiol; 2016 Dec; 311(6):L1076-L1081. PubMed ID: 27760764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary hypertension in extremely preterm infants: a call to standardize echocardiographic screening and follow-up policy.
    Arjaans S; Zwart EAH; Roofthooft M; Kooi EMW; Bos AF; Berger RMF
    Eur J Pediatr; 2021 Jun; 180(6):1855-1865. PubMed ID: 33528615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk factors and prognosis of bronchopulmonary dysplasia associated pulmonary hypertension in preterm infants].
    Chen C; Huang P; Lin BC; Chen XY; Zhao J; Sun HY; Yu YL; Chen S; Qiu XM; Yang CZ
    Zhonghua Er Ke Za Zhi; 2020 Sep; 58(9):747-752. PubMed ID: 32872715
    [No Abstract]   [Full Text] [Related]  

  • 12. Bronchopulmonary dysplasia-associated pulmonary hypertension: clues from placental pathology.
    Kunjunju AM; Gopagondanahalli KR; Chan Y; Sehgal A
    J Perinatol; 2017 Dec; 37(12):1310-1314. PubMed ID: 28880261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early cardiac function and death, severe bronchopulmonary dysplasia and pulmonary hypertension in extremely preterm infants.
    Moore SS; De Carvalho Nunes G; Dancea A; Wutthigate P; Simoneau J; Beltempo M; Sant'Anna G; Altit G
    Pediatr Res; 2024 Jan; 95(1):293-301. PubMed ID: 37726544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placental pathologic changes of maternal vascular underperfusion in bronchopulmonary dysplasia and pulmonary hypertension.
    Mestan KK; Check J; Minturn L; Yallapragada S; Farrow KN; Liu X; Su E; Porta N; Gotteiner N; Ernst LM
    Placenta; 2014 Aug; 35(8):570-4. PubMed ID: 24906549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placental Villous Vascularity Is Decreased in Premature Infants with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension.
    Yallapragada SG; Mestan KK; Palac H; Porta N; Gotteiner N; Hamvas A; Grobman W; Ernst LM
    Pediatr Dev Pathol; 2016; 19(2):101-7. PubMed ID: 26366786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Umbilical cord blood metabolomics reveal distinct signatures of dyslipidemia prior to bronchopulmonary dysplasia and pulmonary hypertension.
    La Frano MR; Fahrmann JF; Grapov D; Pedersen TL; Newman JW; Fiehn O; Underwood MA; Mestan K; Steinhorn RH; Wedgwood S
    Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L870-L881. PubMed ID: 30113229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of pulmonary hypertension on neurodevelopmental outcome in preterm infants with bronchopulmonary dysplasia: a cohort study.
    Nakanishi H; Uchiyama A; Kusuda S
    J Perinatol; 2016 Oct; 36(10):890-6. PubMed ID: 27442157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary hypertension associated with bronchopulmonary dysplasia in preterm infants.
    Bui CB; Pang MA; Sehgal A; Theda C; Lao JC; Berger PJ; Nold MF; Nold-Petry CA
    J Reprod Immunol; 2017 Nov; 124():21-29. PubMed ID: 29035757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRIB scores as a tool for assessing risk for the development of pulmonary hypertension in extremely preterm infants with bronchopulmonary dysplasia.
    Bruno CJ; Meerkov M; Capone C; Vega M; Sutton N; Kim M; Wang D; Fuloria M
    Am J Perinatol; 2015 Sep; 32(11):1031-7. PubMed ID: 26368789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel biomarkers of bronchopulmonary dysplasia and bronchopulmonary dysplasia-associated pulmonary hypertension.
    Sahni M; Yeboah B; Das P; Shah D; Ponnalagu D; Singh H; Nelin LD; Bhandari V
    J Perinatol; 2020 Nov; 40(11):1634-1643. PubMed ID: 32811975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.